Join over 450 leaders at the renowned Biomarkers Series, discussing key opportunities and challenges in biomarker research and precision medicine
Featuring over 50 presentations, the event brings together leading pharma, biotech and academic organisations working in the biomarker space across multiple therapeutic areas, enabling attendees to gain insights into the latest novel biomarker data and technologies
Over 450 attendees representing global pharmaceutical organisations, leading biotech & diagnostic companies and internationally renowned academic and healthcare institutions working in the biomarker space across multiple therapeutic areas
Over 50 presentation and case studies focussed on the key opportunities and challenges in translational science, personalised medicine and clinical development
15 October 2020 – Day One
16 October 2020 – Day Two
This event is co-located with the virtual event 3rd Annual Advances in Immuno-Oncology USA Congress.
Attendees will have full access to both events.
The 2020 Series again brings together a panel of prominent leaders and scientists, sharing new case studies, innovative data and industry outlook.
The following were confirmed speakers for the 2019 series.
Networking & knowledge-sharing is at the heart of what we do. Alongside the innovative programme, attendees can engage in a variety of Series features and make the most of participation in a range of virtual experiences.
*Free passes are only available to industry R&D or academia.